FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891667032> ?p ?o ?g. }

• W2891667032 abstract "Cell therapy with bone marrow (BM)-derived progenitors has emerged as a promising therapeutic for refractory angina (RA) patients. In the present study, we evaluated the safety and preliminary efficacy of transcatheter delivery of autologous BM-derived advanced therapy medicinal product CD133+ cells (ATMP-CD133) in RA patients, correlating perfusion outcome with cell function.In the phase I Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO) trial, a total of 10 patients with left ventricular (LV) dysfunction (ejection fraction ≤ 45%) and evidence of reversible ischemia, as assessed by single-photon emission computed tomography (SPECT), underwent BM aspiration and fluoroscopy-based percutaneous endomyocardial delivery of ATMP-CD133. Patients were evaluated at 6 and 12 months for safety and preliminary efficacy endpoints. ATMP-CD133 samples were used for in vitro correlations.Patients were treated safely with a mean number of 6.57 ± 3.45 × 106 ATMP-CD133. At 6-month follow-up, myocardial perfusion at SPECT was significantly ameliorated in terms of changes in summed stress (from 18.2 ± 8.6 to 13.8 ± 7.8, p = 0.05) and difference scores (from 12.0 ± 5.3 to 6.1 ± 4.0, p = 0.02) and number of segments with inducible ischemia (from 7.3 ± 2.2 to 4.0 ± 2.7, p = 0.003). Similarly, Canadian Cardiovascular Society and New York Heart Association classes significantly improved at follow-up vs baseline (p ≤ 0.001 and p = 0.007, respectively). Changes in summed stress score changes positively correlated with ATMP-CD133 release of proangiogenic cytokines HGF and PDGF-bb (r = 0.80, p = 0.009 and r = 0.77, p = 0.01, respectively) and negatively with the proinflammatory cytokines RANTES (r = - 0.79, p = 0.01) and IL-6 (r = - 0.76, p = 0.02).Results of the RECARDIO trial suggested safety and efficacy in terms of clinical and perfusion outcomes in patients with RA and LV dysfunction. The observed link between myocardial perfusion improvements and ATMP-CD133 secretome may represent a proof of concept for further mechanistic investigations.ClinicalTrials.gov, NCT02059681 . Registered 11 February 2014." @default.
• W2891667032 created "2018-09-27" @default.
• W2891667032 creator A5003427721 @default.
• W2891667032 creator A5006512242 @default.
• W2891667032 creator A5017458827 @default.
• W2891667032 creator A5020033102 @default.
• W2891667032 creator A5040177410 @default.
• W2891667032 creator A5042991800 @default.
• W2891667032 creator A5048154678 @default.
• W2891667032 creator A5051485159 @default.
• W2891667032 creator A5054027791 @default.
• W2891667032 creator A5056136982 @default.
• W2891667032 creator A5059129504 @default.
• W2891667032 creator A5059467892 @default.
• W2891667032 creator A5061735743 @default.
• W2891667032 creator A5063057398 @default.
• W2891667032 creator A5071817385 @default.
• W2891667032 creator A5074531142 @default.
• W2891667032 creator A5083769556 @default.
• W2891667032 creator A5087605838 @default.
• W2891667032 date "2018-09-14" @default.
• W2891667032 modified "2023-09-26" @default.
• W2891667032 title "Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO)" @default.
• W2891667032 cites W1502749851 @default.
• W2891667032 cites W1512068307 @default.
• W2891667032 cites W1873388266 @default.
• W2891667032 cites W1963454290 @default.
• W2891667032 cites W1964774705 @default.
• W2891667032 cites W1968750133 @default.
• W2891667032 cites W1975102797 @default.
• W2891667032 cites W1978238305 @default.
• W2891667032 cites W1978347107 @default.
• W2891667032 cites W1979833231 @default.
• W2891667032 cites W1981724886 @default.
• W2891667032 cites W1983488763 @default.
• W2891667032 cites W1986451583 @default.
• W2891667032 cites W1988592291 @default.
• W2891667032 cites W1998285493 @default.
• W2891667032 cites W1998476642 @default.
• W2891667032 cites W1999634551 @default.
• W2891667032 cites W2005874682 @default.
• W2891667032 cites W2009293798 @default.
• W2891667032 cites W2011849709 @default.
• W2891667032 cites W2014368942 @default.
• W2891667032 cites W2025110798 @default.
• W2891667032 cites W2049584490 @default.
• W2891667032 cites W2089903375 @default.
• W2891667032 cites W2090076255 @default.
• W2891667032 cites W2097401006 @default.
• W2891667032 cites W2099628362 @default.
• W2891667032 cites W2101099004 @default.
• W2891667032 cites W2101533862 @default.
• W2891667032 cites W2103878792 @default.
• W2891667032 cites W2103987592 @default.
• W2891667032 cites W2105840074 @default.
• W2891667032 cites W2107501191 @default.
• W2891667032 cites W2115260446 @default.
• W2891667032 cites W2129396577 @default.
• W2891667032 cites W2137812648 @default.
• W2891667032 cites W2143298795 @default.
• W2891667032 cites W2162412444 @default.
• W2891667032 cites W2169283169 @default.
• W2891667032 cites W2191555706 @default.
• W2891667032 cites W2237239357 @default.
• W2891667032 cites W2312256951 @default.
• W2891667032 cites W2346955045 @default.
• W2891667032 cites W2425329208 @default.
• W2891667032 cites W2429160339 @default.
• W2891667032 cites W2508655590 @default.
• W2891667032 cites W2531336843 @default.
• W2891667032 cites W2590952348 @default.
• W2891667032 cites W2617434477 @default.
• W2891667032 cites W2739974728 @default.
• W2891667032 cites W2772646551 @default.
• W2891667032 cites W2773957131 @default.
• W2891667032 cites W2781806513 @default.
• W2891667032 cites W2884605759 @default.
• W2891667032 doi "https://doi.org/10.1186/s13287-018-0969-z" @default.
• W2891667032 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6137884" @default.
• W2891667032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30217223" @default.
• W2891667032 hasPublicationYear "2018" @default.
• W2891667032 type Work @default.
• W2891667032 sameAs 2891667032 @default.
• W2891667032 citedByCount "12" @default.
• W2891667032 countsByYear W28916670322019 @default.
• W2891667032 countsByYear W28916670322020 @default.
• W2891667032 countsByYear W28916670322021 @default.
• W2891667032 countsByYear W28916670322022 @default.
• W2891667032 countsByYear W28916670322023 @default.
• W2891667032 crossrefType "journal-article" @default.
• W2891667032 hasAuthorship W2891667032A5003427721 @default.
• W2891667032 hasAuthorship W2891667032A5006512242 @default.
• W2891667032 hasAuthorship W2891667032A5017458827 @default.
• W2891667032 hasAuthorship W2891667032A5020033102 @default.
• W2891667032 hasAuthorship W2891667032A5040177410 @default.
• W2891667032 hasAuthorship W2891667032A5042991800 @default.
• W2891667032 hasAuthorship W2891667032A5048154678 @default.
• W2891667032 hasAuthorship W2891667032A5051485159 @default.
• W2891667032 hasAuthorship W2891667032A5054027791 @default.
• W2891667032 hasAuthorship W2891667032A5056136982 @default.

• next